Rose PG - Search Results

1

Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: a Gynecologic Oncology Group study.

Farley J, Sill MW, Birrer M, Walker J, Schilder RJ, Thigpen JT, Coleman RL, Miller BE, Rose PG, Lankes HA. Farley J, et al. Among authors: rose pg. Gynecol Oncol. 2011 May 1;121(2):303-8. doi: 10.1016/j.ygyno.2011.01.030. Epub 2011 Feb 16. Gynecol Oncol. 2011. PMID: 21329967 Free PMC article. Clinical Trial.

2

Advanced cervical carcinoma presenting with toxic shock syndrome.

Rose PG, Wilson G. Rose PG, et al. Gynecol Oncol. 1994 Feb;52(2):264-6. doi: 10.1006/gyno.1994.1043. Gynecol Oncol. 1994. PMID: 8314150

3

Serous papillary carcinoma of the cervix.

Rose PG, Reale FR. Rose PG, et al. Gynecol Oncol. 1993 Sep;50(3):361-4. doi: 10.1006/gyno.1993.1226. Gynecol Oncol. 1993. PMID: 8406202

4

Advanced ovarian carcinoma managed in an HIV-positive patient.

Rose PG, Cheeseman SH. Rose PG, et al. Gynecol Oncol. 1993 Jan;48(1):132-4. doi: 10.1006/gyno.1993.1022. Gynecol Oncol. 1993. PMID: 8423016

5

A phase II study of weekly cisplatin followed by cisplatin and ifosfamide in advanced or recurrent cervical carcinoma.

Rose PG, Piver MS, Malfetano JH, Baker TR, Hempling RE, Recio FO. Rose PG, et al. Cancer. 1993 Apr 1;71(7):2245-9. doi: 10.1002/1097-0142(19930401)71:7<2245::aid-cncr2820710714>3.0.co;2-p. Cancer. 1993. PMID: 8453545 Clinical Trial.

6

Operative retroperitoneal ureteral catheterization for obstructive uropathy in primary locally advanced carcinoma of the cervix: description of a technique and experience.

Rose PG. Rose PG. Gynecol Oncol. 1996 Apr;61(1):79-82. doi: 10.1006/gyno.1996.0100. Gynecol Oncol. 1996. PMID: 8626122 Clinical Trial.

7

Phase II evaluation of altretamine for advanced or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.

Rose PG, Blessing JA, Arseneau J. Rose PG, et al. Gynecol Oncol. 1996 Jul;62(1):100-2. doi: 10.1006/gyno.1996.0196. Gynecol Oncol. 1996. PMID: 8690279 Clinical Trial.

8

A phase II trial of prolonged oral etoposide (VP-16) as second-line therapy for advanced and recurrent endometrial carcinoma: a Gynecologic Oncology Group study.

Rose PG, Blessing JA, Lewandowski GS, Creasman WT, Webster KD. Rose PG, et al. Gynecol Oncol. 1996 Oct;63(1):101-4. doi: 10.1006/gyno.1996.0286. Gynecol Oncol. 1996. PMID: 8898177 Clinical Trial.

9

Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.

Rose PG, Blessing JA, Van Le L, Waggoner S. Rose PG, et al. Gynecol Oncol. 1998 Aug;70(2):263-6. doi: 10.1006/gyno.1998.5097. Gynecol Oncol. 1998. PMID: 9740702 Clinical Trial.

10

Prolonged oral etoposide in recurrent or advanced leiomyosarcoma of the uterus: a gynecologic oncology group study.

Rose PG, Blessing JA, Soper JT, Barter JF. Rose PG, et al. Gynecol Oncol. 1998 Aug;70(2):267-71. doi: 10.1006/gyno.1998.5080. Gynecol Oncol. 1998. PMID: 9740703 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

327 results

Search Page

Filters